D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
The RMR Group
RMR
$342M
| $297K | ﹤0.01% |
4,868
-2,214
| -31% | -$146K |
|
|
AKS
3177
PUT
DELISTED
AK Steel Holding Corp
AKS
| $297K | ﹤0.01% |
108,100
+8,100
| +8% | +$23K |
|
|
NBRV
3178
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $296K | ﹤0.01% |
+485
| New | +$265K |
|
3179
WEX
WEX
$6.11B
| $295K | ﹤0.01% |
1,536
-84,768
| -98% | -$14.3M |
|
3180
American International
AIG
$41.9B
| $294K | ﹤0.01% |
6,830
-195,564
| -97% | -$8.36M |
|
3181
Globalstar
GSAT
$10.2B
| $294K | ﹤0.01% |
45,603
-222,230
| -83% | -$1.89M |
|
3182
CALL
Lumentum
LITE
$59.4B
| $294K | ﹤0.01% |
+5,200
| New | +$249K |
|
|
CY
3183
DELISTED
Cypress Semiconductor
CY
| $294K | ﹤0.01% |
+19,720
| New | +$286K |
|
|
MITT
3184
TPG Mortgage Investment Trust
MITT
$230M
| $292K | ﹤0.01% |
5,776
-23,989
| -81% | -$1.26M |
|
3185
CALL
Insmed
INSM
$23.2B
| $291K | ﹤0.01% |
10,000
| – | – |
|
|
TLGT
3186
DELISTED
Teligent, Inc
TLGT
| $291K | ﹤0.01% |
25,116
+4,743
| +23% | +$71.5K |
|
3187
Baker Hughes
BKR
$56.8B
| $290K | ﹤0.01% |
10,450
-6,635
| -39% | -$168K |
|
3188
Comstock Resources
CRK
$3.97B
| $289K | ﹤0.01% |
+41,771
| New | +$275K |
|
3189
Fox Factory Holding Corp
FOXF
$776M
| $289K | ﹤0.01% |
4,135
-12,103
| -75% | -$768K |
|
3190
FreightCar America
RAIL
$275M
| $289K | ﹤0.01% |
47,051
+15,738
| +50% | +$116K |
|
3191
NACCO Industries
NC
$353M
| $288K | ﹤0.01% |
7,531
+100
| +1% | +$3.65K |
|
3192
PDS Biotechnology
PDSB
$38.1M
| $288K | ﹤0.01% |
38,934
+1,746
| +5% | +$14.6K |
|
|
CTT
3193
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $286K | ﹤0.01% |
29,077
-143,434
| -83% | -$1.31M |
|
3194
CALL
Applied Industrial Technologies
AIT
$12.8B
| $285K | ﹤0.01% |
+4,800
| New | +$278K |
|
3195
Align Technology
ALGN
$12B
| $284K | ﹤0.01% |
1,000
-9,707
| -91% | -$2.32M |
|
3196
CONMED
CNMD
$1.29B
| $284K | ﹤0.01% |
3,412
-21,791
| -86% | -$1.58M |
|
3197
CALL
Agnico Eagle Mines
AEM
$72.6B
| $283K | ﹤0.01% |
6,500
-7,800
| -55% | -$330K |
|
3198
CALL
Core Laboratories
CLB
$538M
| $283K | ﹤0.01% |
4,100
-8,300
| -67% | -$556K |
|
3199
China Yuchai International
CYD
$1.69B
| $283K | ﹤0.01% |
17,848
-10,277
| -37% | -$166K |
|
3200
Lifecore Biomedical
LFCR
$162M
| $283K | ﹤0.01% |
23,068
+12,648
| +121% | +$154K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.